Evidence map›Paper›PMID 33535602›Full record

ArticleLife (Basel, Switzerland)2021

The Lanostane Triterpenoids in

Chien-Liang Chao, Hsin-Wen Huang, Muh-Hwan Su, Hang-Ching Lin, Wen-Mein Wu

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. The Role ofMolecules (Basel, Switzerland) · 2025
    Review
  6. Review
  7. Molecules (Basel, Switzerland) · 2024
    Article
  8. Effect ofInternational journal of molecular sciences · 2024
    Article
  9. Article
  10. Review
  11. Two new lanostanoid glycosides isolated from a Kenyan polyporeBeilstein journal of organic chemistry · 2023
    Article
  12. Review
  13. Three main metabolites fromFrontiers in pharmacology · 2022
    Article
  14. Mushrooms as future generation healthy foods.Frontiers in nutrition · 2022
    Review
  15. Article
  16. Life (Basel, Switzerland) · 2021
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Chien-Liang ChaoSinphar Pharmaceutical Co., Ltd., Sinphar Group, Yilan 269, Taiwan.
Hsin-Wen HuangSinphar Pharmaceutical Co., Ltd., Sinphar Group, Yilan 269, Taiwan.
Muh-Hwan SuSinphar Pharmaceutical Co., Ltd., Sinphar Group, Yilan 269, Taiwan.
Hang-Ching LinSinphar Pharmaceutical Co., Ltd., Sinphar Group, Yilan 269, Taiwan.
Wen-Mein WuDepartment of Nutritional Science, Fu-Jen Catholic University, Hsinchuang 24205, Taiwan.ORCID 0000-0002-8143-0939
National Defense Medical Center · TWFu Jen Catholic University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

immunoregulationimmunotoxicitylanostane triterpenoidsPoria cocosTh1/Th2

Identifiers

PMID33535602
PMCPMC7912843
OpenAlexW3128252852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.